- News & Features
Many women with autoimmune conditions wonder whether they should stop or continue their medications during pregnancy or breastfeeding. Patients often ask if it is riskier to stop medication or continue them while trying to conceive, during pregnancy and while breastfeeding. What should be considered when evaluating the safety, risks, and benefits of medications during these periods? How do you weigh the impact of both the disease and its treatment on your own health and your baby’s?
Click on the video below to see the video from the webinar.
Dr. Megan Clowse, rheumatologist in Durham, North Carolina and an Associate Professor of Medicine at Duke University was joined by CreakyJoints patients and staff for a one-hour webinar to discuss these important topics. Her research focuses on the management of rheumatologic diseases in patients of childbearing age and includes the Duke Autoimmunity in Pregnancy Registry which includes over 500 pregnancies in women with rheumatic disease seen in the last decade. Dr. Clowse is also leading the Reproductive Concerns Research Interest Group (RIG) which is part of a larger collaborative research group called the Autoimmune and Systemic Inflammatory Syndromes Collaborative Research Group (ASIS CRG), part of PCORnet, the National Patient-Centered Clinical Research Network. The presentation was followed by a Q&A session with Dr. Clowse, an expert in the field.
Here are a few of our key learnings:
The above are just a few takeaways from the one-hour event. Check out the embedded video above, or head over to youtube.com/creakyjoints to view the webinar in its entirety.
To learn more about the PCORnet Autoimmune and Systemic Inflammatory Syndromes Collaborative Research Group (ASIS CRG), click here.